We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Siemens Healthineers

Provides customized electronic systems and advanced imaging, diagnostics, therapy, and healthcare IT solutions for th... read more Featured Products: More products

Download Mobile App




Siemens Rebrands its Healthcare Business

By HospiMedica International staff writers
Posted on 09 May 2016
Siemens Healthcare has been rebranded itself as Siemens Healthineers underlining the company’s expertise in the healthcare industry.

Siemens Healthineers (Erlangen, Germany) will leverage this expertise to provide a wider range of customized clinical solutions to support their customers, and will continue to strengthen their portfolio across the medical imaging and laboratory diagnostics business. More...
In addition, the company will add new offerings, such as managed services, consulting and digital services, and further technologies to strengthen its position in the growing market of therapeutic and molecular diagnostics. The name of the legal entities will remain unchanged.

As part of its Vision 2020 strategy, Siemens (Munich, Germany) announced in 2014 that its healthcare business would be separately managed as a company within the company, with a new organizational setup, so as to close the gap with more profitable competitors such as ABB (Zurich, Switzerland) and General Electric. The rebranding, as well as the addition of new healthcare capabilities and the separation of the business, strengthens long-standing speculation that Siemens is planning an initial public offering (IPO) of the healthcare business.

“We have an exceptional track record of engineering and scientific excellence and are consistently at the forefront of developing innovative clinical solutions that enable providers to offer efficient, high quality patient care,” said Bernd Montag, CEO of Siemens Healthineers. “Our new brand is a bold signal for our ambition and expresses our identity as a people company - 45,000 employees worldwide who are passionate about empowering healthcare providers to optimally serve their patients.”

In 2014 Siemens sold off its hospital IT business, then Siemens Health Services, to Cerner (Kansas City, MO, USA), a provider of healthcare IT services, for USD 1.3 billion. A that time, the company said it would focus its efforts in the healthcare IT area on the development of systems for its laboratory diagnostics sector, as well as its imaging and therapy businesses. Cerner combined the hospital IT business with its own operations, creating an entity with USD 4.5 billion of annual revenue and USD 650 million of annual investments in research and development.

Related Links:
Siemens Healthineers
Siemens
ABB
Cerner


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Gold Member
12-Channel ECG
CM1200B
New
Medical Cart
Medical Carts
New
Pediatric Cast Saw
CSP-201 Quietcast
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: A mechanosensing-based approach offers a potential path to the treatment for cardiac fibrosis (Photo courtesy of Adobe Stock)

Mechanosensing-Based Approach Offers Promising Strategy to Treat Cardiovascular Fibrosis

Cardiac fibrosis, which involves the stiffening and scarring of heart tissue, is a fundamental feature of nearly every type of heart disease, from acute ischemic injuries to genetic cardiomyopathies.... Read more

Surgical Techniques

view channel
Image: Bioprinting synthetic vasculature could dramatically change how cardiovascular diseases are treated (Dell, A.C., Maresca, J., Davis, B.A. et al.; doi.org/10.1038/s41598-025-93276-y)

Bioprinted Aortas Offer New Hope for Vascular Repair

Current treatment options for severe cardiovascular diseases include using grafts made from a patient's own tissue (autologous) or synthetic materials. However, autologous grafts require invasive surgery... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.